A temperature-sensitive Sendai virus for gene editing
Author Information
Author(s): Stevens Christian S., Carmichael Jillian C., Watkinson Ruth, Kowdle Shreyas, Reis Rebecca A., Hamane Kory, Jang Jason, Park Arnold, Pernet Olivier, Khamaikawin Wannisa, Hong Patrick, Thibault Patricia, Gowlikar Aditya, An Dong Sung, Lee Benhur
Primary Institution: Icahn School of Medicine at Mount Sinai
Hypothesis
Can a temperature-sensitive Sendai virus serve as a safe and effective delivery vector for CRISPR-Cas9 gene editing?
Conclusion
The temperature-sensitive Sendai virus platform shows high efficiency in gene editing with minimal immune response, making it a promising tool for gene therapy.
Supporting Evidence
- The ts SeV vector achieved over 90% editing efficiency in human CD34+ HSPCs.
- CCR5 editing exceeded 90% in primary human CD14+ monocytes.
- The engineered virus showed minimal induction of an innate immune response.
- Transduced HSPCs maintained multilineage colony formation potential.
Takeaway
Researchers created a special virus that can help fix genes without making people sick, and it works really well in certain types of blood cells.
Methodology
The study involved developing a temperature-sensitive Sendai virus and testing its ability to deliver CRISPR-Cas9 for gene editing in human cells.
Potential Biases
Potential biases may arise from the selection of specific cell types and the experimental conditions used.
Limitations
The study primarily focused on specific cell types and may not be generalizable to all human cells.
Participant Demographics
Human CD34+ hematopoietic stem and progenitor cells and CD14+ monocytes were used from multiple donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website